Byoung-Gie Kim

34PUBLICATIONS
220CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Aerospace materialsMedical ethics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Sep 26, 2026
Effectiveness of first-line niraparib maintenance in Korean patients with advanced ovarian cancer: a multicenter retrospective cohort study.

|Jun 12, 2026
Diagnostic performance of cervical cytology in HPV-independent cervical cancer: a comparative analysis with HPV-associated cases.

|Jan 29, 2026
Maintenance of PARP Inhibitor Rechallenge plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.

Hyun-Woong Cho, Jeong-Yeol Park, Myong Cheol Lim

|Jan 09, 2026
Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE).

Se Ik Kim, Hyun-Woong Cho, Chel Hun Choi

|Sep 19, 2025
Erratum: The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.

David Tan, Noriko Fujiwara, Keiichi Fujiwara

|Apr 04, 2025
Significance of HPV status on tumor response and treatment outcomes in endocervical adenocarcinoma treated with definitive chemoradiotherapy: a retrospective study.

Jong Yun Baek, Hyun-Soo Kim, Won Kyung Cho

Pageof 6

Frequent Collaborators

15 joint publications

Chel Hun Choi

13 joint publications

Jae-Weon Kim

12 joint publications

Tae-Joong Kim

8 joint publications

Jung-Yun Lee